IMMX

10.97

0.46% 0.05

Dopo l'orario di chiusura: 10.97

Immix Biopharma Inc (IMMX)

Panoramica Notizia Cronologia dei prezzi Financials Forum Previsione

Precedente Chiudi:

$10.92

Aprire:

$10.85

Volume 24 ore:

1.30M

Relative Volume:

0.72

Capitalizzazione di mercato:

$780.95M

Reddito:

Utile/perdita netta:

$-34.98M

Rapporto P/E:

-11.93

EPS:

-0.9199

Flusso di cassa netto:

$-32.77M

1 W Prestazione:

+12.86%

1M Prestazione:

+2.72%

6M Prestazione:

+49.66%

1 anno Prestazione:

+400.91%

Intervallo 1D:

$10.36

$11.08

Intervallo di 1 settimana:

$9.66

$11.72

Portata 52W:

$1.94

$12.14

Immix Biopharma Inc Stock (IMMX) Company Profile

Nome

Immix Biopharma Inc

Settore

Healthcare (1080)

Industria

Biotechnology (604)

Telefono

(888) 958-1084

Indirizzo

11400 WEST OLYMPIC BLVD., LOS ANGELES

Dipendente

Cinguettio

Prossima data di guadagno

2026-08-14

Ultimi documenti SEC

IMMX's Discussions on Twitter

Compare IMMX vs VRTX, REGN, ARGX, RVMD, ONC

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
IMMX Immix Biopharma Inc	10.97	809.43M	0	-34.98M	-32.77M	-0.9199
VRTX Vertex Pharmaceuticals Inc	505.75	133.25B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	803.48	82.16B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	851.29	54.80B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	203.71	43.99B	742.00K	-1.37B	-1.07B	-7.0731
ONC Beone Medicines Ltd Adr	347.48	40.62B	5.76B	514.49M	1.10B	4.4813

Immix Biopharma Inc Stock (IMMX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-03-25	Iniziato	Morgan Stanley	Overweight
2026-03-09	Iniziato	Citizens	Mkt Outperform
2026-02-09	Iniziato	Mizuho	Outperform

Immix Biopharma Inc Borsa (IMMX) Ultime notizie

Aug 14, 2026

Immix Biopharma Stock Price Forecast. Should You Buy IMMX? - StockInvest.us

Aug 14, 2026

Immix Biopharma (NASDAQ:IMMX) Stock Price Down 4.5%Here's Why - marketbeat.com

Aug 14, 2026

Immix Biopharma (IMMX) gains 5.6% stake holder led by Eventide Asset Management - Stock Titan

Aug 14, 2026

Citizens reiterates Immix Biopharma stock rating on pipeline progress - Investing.com

Aug 14, 2026

Citizens reiterates Immix Biopharma stock rating on pipeline progress By Investing.com - Investing.com India

Aug 14, 2026

Morgan Stanley Adjusts PT on Immix Biopharma to $19 From $20, Maintains Overweight Rating - moomoo.com

Aug 14, 2026

Aug 13, 2026

Janus Henderson Group (IMMX) discloses 9.78M-share beneficial stake in Immix Biopharma - Stock Titan

Aug 13, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Immix Biopharma, Inc.IMMX - PR Newswire

Aug 13, 2026

Aug 12, 2026

Immix Biopharma publishes corporate presentation on NXC-201 BCMA CAR-T in relapsed/refractory AL amyloidosis - Bitget

Aug 11, 2026

Immix Biopharma, Inc. Stock 12‑Month Price Target Cut to $20.44, Implies 102% Upside - TradingView

Aug 11, 2026

Immix Biopharma (IMMX) Short Interest & Short Float | Updated Aug 2026 - marketbeat.com

Aug 11, 2026

Aug 10, 2026

IMMIX BIOPHARMA, INC. : H.C. WAINWRIGHT RAISES TARGET PRICE TO $25 FROM $20 - Bitget

Aug 10, 2026

H.C. Wainwright raises Immix Biopharma price target to $25 By Investing.com - Investing.com Australia

Aug 10, 2026

H.C. Wainwright raises Immix Biopharma price target to $25 - Investing.com India

Aug 10, 2026

Regulatory and Data Risks Loom Over Immix Biopharma’s Clinical Programs and Valuation - TipRanks

Aug 10, 2026

Aug 07, 2026

Immix Biopharma (NASDAQ:IMMX) Announces Quarterly Earnings Results - marketbeat.com

Aug 07, 2026

Immix Biopharma (NASDAQ: IMMX) ends Q2 2026 with $232.1M in cash - Stock Titan

Aug 07, 2026

Immix Biopharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

Aug 07, 2026

Immix Biopharma (NASDAQ:IMMX) Stock Price Down 6.7%Here's What Happened - marketbeat.com

Aug 07, 2026